JIC
CYTR

Joel Isaacson & Co’s CytRx Corp CYTR Stock Holding History

Joel Isaacson & Co’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,667
Closed -$22K – 760
2016
Q2 		$22K Hold
1,667
– – ﹤0.01% 455
2016
Q1 		$27K Buy
+1,667
New +$22.8K 0.01% 438
2015
Q2 		– Sell
-4,167
Closed -$84K – 810
2015
Q1 		$84K Hold
4,167
– – 0.02% 279
2014
Q4 		$69K Buy
+4,167
New +$65K 0.02% 280

Other funds holding CYTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Joel Isaacson & Co's CYTR Position: Q3 2016 in Review

Joel Isaacson & Co sold out of CytRx Corp (CYTR) in Q3 2016, closing a stake of 1,667 shares — an estimated $22K sold.

Joel Isaacson & Co first reported a position in CYTR in Q4 2014 and held it in 4 quarters. The position peaked at $84K in Q1 2015. 72 funds tracked by Wall St. Rank hold CYTR as of Q3 2016.

  • Joel Isaacson & Co reported no remaining CytRx Corp position as of Q3 2016 after selling out during the quarter.
  • Joel Isaacson & Co sold 1,667 CytRx Corp shares in Q3 2016, an estimated $22K.
  • Joel Isaacson & Co first reported a position in CytRx Corp in Q4 2014 and held it in 4 quarters.
  • Joel Isaacson & Co's CytRx Corp position peaked at $84K in Q1 2015.
  • 72 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2016.

Based on Joel Isaacson & Co's 13F filing for Q3 2016, filed 25 Oct 2016.